Erik P Kohler, MD | |
8730 Sonora Cir, Eagle River, AK 99577-9403 | |
(907) 982-0779 | |
Not Available |
Full Name | Erik P Kohler |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 8730 Sonora Cir, Eagle River, Alaska |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255379731 | NPI | - | NPPES |
MD5237 | Medicaid | AK |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 5237 (Alaska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Erik P Kohler, MD 8730 Sonora Circle, Eagle River, AK 99508 Ph: (907) 982-0779 | Erik P Kohler, MD 8730 Sonora Cir, Eagle River, AK 99577-9403 Ph: (907) 982-0779 |
News Archive
Ear infections are one of the most common health problems for children, with most kids experiencing at least one by their third birthday. Annual costs in the United States alone are in the billions of dollars.
When patients with life-threatening bacterial infections are allergic to antibiotics, drug desensitization may be an option when no other alternative exists according to a report published this month in Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
Researchers at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, and Duke University have discovered a cause of airway irritation and wheezing after exposure to ozone, a common urban air pollutant.
If you are one the thousands of people each year considering aesthetic plastic surgery, MidAmerica Plastic Surgery has some good news for you. Recent advances in three dimensional (3D) photography combined with revolutionary new software allow prospective patients to preview what they will look like as the result of breast augmentation, facial procedures, and more, well in advance of any surgery.
An assay to aid in the early detection of HIV infection may soon be available in the United States. Abbott announced today it has submitted a Premarket Approval application for the ARCHITECT HIV Ag/Ab Combo assay to the U.S. Food and Drug Administration (FDA) for expedited review. Upon approval, the assay is expected to be the first test available in the United States to simultaneously detect the combined presence of HIV antigens (proteins produced by the HIV virus) and antibodies (proteins produced by the body to fight HIV antigens), which would allow for the early detection and ongoing monitoring of the virus.
› Verified 8 days ago